Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea.
Diabetes Metab J. 2022 May;46(3):417-426. doi: 10.4093/dmj.2022.0106. Epub 2022 May 25.
This study aimed to investigate the prevalence and management of diabetes mellitus, risk-factor control, and comorbidities among Korean adults.
We conducted a cross-sectional analysis of data from the Korea National Health and Nutrition Examination Survey to assess the prevalence, treatment, risk factors, comorbidities, and self-management behaviors of diabetes mellitus from 2019 to 2020. We also analyzed data from the Korean National Health Insurance Service to evaluate the use of antidiabetic medications in people with diabetes mellitus from 2002 through 2018.
Among Korean adults aged 30 years or older, the estimated prevalence of diabetes mellitus was 16.7% in 2020. From 2019 through 2020, 65.8% of adults with diabetes mellitus were aware of the disease and treated with antidiabetic medications. The percentage of adults with diabetes mellitus who achieved glycosylated hemoglobin (HbA1c) <6.5% was 24.5% despite the increased use of new antidiabetic medications. We found that adults with diabetes mellitus who achieved all three goals of HbA1c <6.5%, blood pressure (BP) <140/85 mm Hg, and low-density lipoprotein cholesterol <100 mg/dL were 9.7%. The percentage of self-management behaviors was lower in men than women. Excess energy intake was observed in 16.7% of adults with diabetes mellitus.
The prevalence of diabetes mellitus among Korean adults remained high. Only 9.7% of adults with diabetes mellitus achieved all glycemic, BP, and lipid controls from 2019 to 2020. Continuous evaluation of national diabetes statistics and a national effort to increase awareness of diabetes mellitus and improve comprehensive diabetes care are needed.
本研究旨在调查韩国成年人中糖尿病的患病率和管理、危险因素控制以及合并症情况。
我们对 2019 年至 2020 年韩国国家健康和营养检查调查的数据进行了横断面分析，以评估糖尿病的患病率、治疗、危险因素、合并症和自我管理行为。我们还分析了 2002 年至 2018 年韩国国家健康保险服务的数据，以评估糖尿病患者使用抗糖尿病药物的情况。
在年龄 30 岁及以上的韩国成年人中，2020 年糖尿病的估计患病率为 16.7%。从 2019 年到 2020 年，65.8%的糖尿病患者知晓该疾病并接受抗糖尿病药物治疗。尽管新型抗糖尿病药物的使用有所增加，但糖尿病患者中糖化血红蛋白（HbA1c）<6.5%的比例仅为 24.5%。我们发现，尽管 HbA1c<6.5%、血压（BP）<140/85mmHg 和低密度脂蛋白胆固醇<100mg/dL 这三个目标均达到的糖尿病患者仅占 9.7%。在男性中，自我管理行为的比例低于女性。在糖尿病患者中，有 16.7%的人存在能量摄入过量的情况。
韩国成年人中糖尿病的患病率仍然很高。在 2019 年至 2020 年期间，仅有 9.7%的糖尿病患者实现了所有血糖、血压和血脂控制目标。需要持续评估国家糖尿病统计数据，并开展国家行动，以提高对糖尿病的认识并改善全面的糖尿病护理。
